1. Home
  2. NREF vs NYXH Comparison

NREF vs NYXH Comparison

Compare NREF & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NREF
  • NYXH
  • Stock Information
  • Founded
  • NREF 2019
  • NYXH 2009
  • Country
  • NREF United States
  • NYXH Belgium
  • Employees
  • NREF N/A
  • NYXH N/A
  • Industry
  • NREF Real Estate Investment Trusts
  • NYXH Medical/Dental Instruments
  • Sector
  • NREF Real Estate
  • NYXH Health Care
  • Exchange
  • NREF Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • NREF 244.3M
  • NYXH 222.3M
  • IPO Year
  • NREF 2020
  • NYXH 2021
  • Fundamental
  • Price
  • NREF $13.96
  • NYXH $7.70
  • Analyst Decision
  • NREF Hold
  • NYXH Strong Buy
  • Analyst Count
  • NREF 3
  • NYXH 4
  • Target Price
  • NREF $14.50
  • NYXH $14.50
  • AVG Volume (30 Days)
  • NREF 72.7K
  • NYXH 34.2K
  • Earning Date
  • NREF 07-31-2025
  • NYXH 08-05-2025
  • Dividend Yield
  • NREF 14.44%
  • NYXH N/A
  • EPS Growth
  • NREF N/A
  • NYXH N/A
  • EPS
  • NREF 2.59
  • NYXH N/A
  • Revenue
  • NREF $110,996,000.00
  • NYXH $4,716,818.00
  • Revenue This Year
  • NREF $25.18
  • NYXH $323.07
  • Revenue Next Year
  • NREF $3.65
  • NYXH $204.30
  • P/E Ratio
  • NREF $5.35
  • NYXH N/A
  • Revenue Growth
  • NREF 370.78
  • NYXH N/A
  • 52 Week Low
  • NREF $12.14
  • NYXH $5.55
  • 52 Week High
  • NREF $18.09
  • NYXH $11.87
  • Technical
  • Relative Strength Index (RSI)
  • NREF 46.92
  • NYXH 54.93
  • Support Level
  • NREF $13.54
  • NYXH $7.30
  • Resistance Level
  • NREF $14.01
  • NYXH $8.03
  • Average True Range (ATR)
  • NREF 0.38
  • NYXH 0.27
  • MACD
  • NREF 0.02
  • NYXH -0.01
  • Stochastic Oscillator
  • NREF 66.00
  • NYXH 65.75

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: